The PKMYT1 inhibitor RP-6306 has synergistic efficacy with carboplatin in CCNE1 amplified tumor models. (October 2022) - Fourtounis, J.; Gallo, D.; Roulston, A.; Stocco, R.; Martino, G.; Fournier, S.; Aguado, E.; Kryczka, R.; Bhaskaran, V.; Morris, S.; Marshall, C.G.